Theme 09 - Clinical Trials and Trial Design

Acknowledgement

We acknowledge the altruism of the participants and their families, and contributions of the HEALEY ALS Platform Trial research and support staff at each of the participating sites for their contributions to this study.

Acknowledgements

We thank those with ALS participating in the REFINE-ALS study and REFINE-ALS Site Investigators. p-Value communications provided editorial support. Funding provided by MTDA/MTPA.

Acknowledgements

We would like to thank patients for taking part in the study. p-Value communications provided editorial support.

Acknowledgements

Thanks to the participants of ALS Talk and our funder, the James and Jeanie Brown ALS Research Fund.

Acknowledgements

We would like to thank patients for taking part in the study. p-Value communications provided editorial support.

Acknowledgements

We would like to thank patients for taking part in the study.

Acknowledgements

I would like to acknowledge joint contributions from Professor McDermott and Dr Stavroulakis.